Ultragenyx resumed with an Outperform at Raymond James. Raymond James resumed Ultragenyx with an Outperform rating and a price target of $80. Coverage on the stock had been suspended after being rated at Market Perform.
https://thefly.com/landingPageNews.php?id=2868351
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.